Cerevance gains $51M in new funding, will launch trial of CVN424
Cerevance is planning to launch a Phase 2 clinical trial in the second quarter of this year to test…
Articles by Marisa Wexler, MS
Parkinson’s mutations can alter inflammatory immune responses
People with sporadic Parkinson’s disease and those with Parkinson’s-associated mutations in the GBA gene show a distinct immune cell…
Study Examines How Caregiver Strain Affects Patients
People with Parkinson’s disease are more likely to report a good quality of life if their caregivers are not…
Rehab Center Will Test Outpatient Monitoring System
Shirley Ryan AbilityLab, a rehabilitation center located in Chicago, Illinois, will conduct a study that will use Datos…
Video-based AI System Approved in China for Use in Parkinson’s
Nervtex’s MoDAS artificial intelligence (AI) system has become the first video-based, AI-powered medical device to win regulatory approval for assessing…
ATH434 Preserves Sense of Smell, Aids Neurons in Mouse Model
ATH434, Alterity Therapeutics’ experimental oral therapy, prevented a loss in the sense of smell — an early and common…
Changes in Gene Activity May Cause Disease to Affect Sexes Differently
The activity of multiple genes in the brain varies according to sex among people with Parkinson’s disease, a new…
NOS2 Exhibits Therapeutic Potential in Mouse Study
Suppressing the production of an enzyme called nitric oxide synthase 2 (NOS2) led to reductions in alpha-synuclein-related abnormalities and neuroinflammation…
FDA Lifts Hold on IkT-148009; Trial to Resume Soon
The U.S. Food and Drug Administration (FDA) has lifted its full clinical hold on IkT-148009, Inhibikase Therapeutics’ investigational oral…
7,500 Patients Given Genetic Testing, Counseling via PD GENEration
The PD GENEration study is halfway to its goal of providing free genetic testing and counseling to 15,000 people…